RE:RE:RE:RE:RE:No ClueYes well, thats 2 different uses.
I dont think ACBs comment on premium strains was focused on CBDs ?
But maybe they should go down that path. As they may not be able to compete with other LPs.
Such a nightmare this company has become. HOW THE F did my investment 3 yrs ago dwindle to a 70% loss. Ridicules.